1. Translocation (12;22)(p13;q12) as sole karyotypic abnormality in a patient with nonlymphocytic leukemia
- Author
-
A. Geurts van Kessel, A.J.M. Siepman, J. C. van Gaal, W. van de Klundert, F. Stellink, and H.R. Oosten
- Subjects
Male ,Cancer Research ,Chromosomes, Human, Pair 22 ,Chromosomal translocation ,Biology ,Translocation, Genetic ,hemic and lymphatic diseases ,Genetics ,medicine ,Humans ,Molecular Biology ,In Situ Hybridization, Fluorescence ,Chromosome 12 ,Southern blot ,Chromosomes, Human, Pair 12 ,ABL ,medicine.diagnostic_test ,DNA, Neoplasm ,Middle Aged ,medicine.disease ,Molecular biology ,Leukemia, Myeloid, Acute ,Leukemia ,medicine.anatomical_structure ,Immunology ,Atypical chronic myeloid leukemia ,Bone marrow ,Fluorescence in situ hybridization - Abstract
Cytogenetic analysis of unstimulated bone marrow (BM) and peripheral blood (PB) cells of a patient with clinical features of atypical chronic myeloid leukemia (CML) showed t(12;22)(p13;q12) as the sole karyotypic abnormality. Subsequent fluorescence in situ hybridization (FISH) with abl- and bcr-specific cosmids as well as chromosome 12- and 22-specific DNA libraries and Southern blot analysis confirmed that in this patient t(12;22) does not constitute a cryptic Ph variant. Recently, a few very similar cases were reported by other investigators. The possible significance of this translocation as a new cytogenetic marker for nonlymphocytic leukemia is discussed.
- Published
- 1994
- Full Text
- View/download PDF